ArticleJournal of biological engineering2026
Effect of HIF-1α inhibitor LW6 on chondrogenic properties of mesenchymal stromal cells and chondrocytes in cell sheets under physioxia.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundHypoxia-inducible factor 1 (HIF-1) plays a central role in cartilage homeostasis, and its modulation may influence the performance of cell-based therapies. LW6, an inhibitor of HIF-1α and a potential anti-cancer therapeutic, has not been previously evaluated in cartilage regeneration-related studies and chondrogenic cell sheet systems. The aim of this study was to investigate how LW6 affects the intracellular functions and chondrogenic potential of human bone marrow–derived mesenchymal stromal cells (BMMSCs) and chondrocytes cultured in 2D, and as scaffold-free cell sheets under physioxic (5% O₂) or normoxic (21% O₂) conditions.
resultsPhysioxia enhanced proliferation, suppressed mitochondrial and malate dehydrogenase 2 activity, reduced glycolysis, lowered intracellular calcium but stabilized HIF-1α and increased the expression of chondrogenic genes (SOX9, COL2A1, ACAN) in both cell types. LW6 further reduced metabolic activity and calcium levels, degraded HIF-1α and downregulated chondrogenic gene expression, particularly in chondrocytes. Physioxia also improved cell sheet integration with human cartilage explants and ECM deposition.
conclusionsPhysioxic conditions support cartilage-forming potential and improve biointegration of BMMSC and chondrocyte cell sheets with human cartilage explants, while HIF-1α modulator LW6 negatively affects chondrogenic and metabolic pathways. These findings provide new insights into how HIF-1-targeting compounds may influence cell–based cartilage engineering and highlight the need for careful consideration of HIF-1 modulation in regenerative applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.